• Medicine · Oct 2020

    Assessment of IGF-1 expression in the peripheral blood of women with recurrent breast cancer.

    • Danylo Rafhael Costa-Silva, Maria da Conceição Barros-Oliveira, Francisco Adelton Alves-Ribeiro, Larysse Cardoso Campos-Verdes, Elmo de Jesus Nery Junior, Samara Fernanda Vieira-Valença, Rodrigo Jose de Vasconcelos-Valença, Veronica Mendes Soares, André Luiz Pinho-Sobral, Emerson Brandão Sousa, Pedro Vitor Lopes-Costa, Dos Santos Alesse Ribeiro AR Getulio Vargas Hospital, Federal University of Piaui, Teresina, Piaui., Jackeline Lopes Viana, Arquimedes Cavalcante Cardoso, Victoria Maria Luz-Borges, Renato de Oliveira Pereira, Cleciton Braga Tavares, Vladimir Costa Silva, Dorival Mendes Rodrigues-Junior, Luiz Henrique Gebrim, and da Silva Benedito Borges BB 0000-0002-9542-7538 Department of Health, Northeast, Postgraduate Program of the Northeast Network of Biotechnology (RENOR.
    • Department of Health, Northeast, Postgraduate Program of the Northeast Network of Biotechnology (RENORBIO).
    • Medicine (Baltimore). 2020 Oct 23; 99 (43): e22890.

    AbstractBreast cancer is the most common malignancy affecting women worldwide. The insulin-like growth factor 1 (IGF-1) gene encodes a protein responsible for a wide variety of physiological processes, including differentiation and cell proliferation. Despite several studies on tumor tissues, no study has evaluated IGF-1 expression in the peripheral blood of women with recurrent breast cancer.In this cross-sectional study, IGF-1 expression in the peripheral blood of 146 women with breast cancer treated approximately 5 years ago was quantified by quantitative reverse transcription polymerase chain. The women were divided into 2 groups: non-recurrence (n = 85) and recurrence (n = 61). Statistical analysis of the data was performed using ANOVA, Mann-Whitney, and Chi-squared tests (P < .05).The results showed no significant difference in IGF-1 expression between the non-recurrence and recurrence groups (P = .988). In the subgroups of patients with lymph node involvement, no statistically significant difference was observed in IGF-1 expression between women with recurrence and those non-recurrence (P = .113). In patients without lymph node metastases, IGF-1 messenger ribonucleic acid (mRNA) expression levels were significantly higher in the non-recurrence group than in the recurrence group (P = .019). Furthermore, using the median IGF-1 mRNA expression as the cutoff point, it was obtained a statistically significant difference in tumor histological grade among women with recurrent breast cancer (P = .042).These data showed significantly higher IGF-1 expression in women without lymph node metastases in the non-recurrence group compared with the recurrence group. In addition, a significant difference was observed in median IGF-1 mRNA expression in relation to tumor histological grade in women with recurrent breast cancer.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…